278 related articles for article (PubMed ID: 18701085)
1. Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function.
Maroof A; Beattie L; Zubairi S; Svensson M; Stager S; Kaye PM
Immunity; 2008 Aug; 29(2):295-305. PubMed ID: 18701085
[TBL] [Abstract][Full Text] [Related]
2. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
Engwerda CR; Smelt SC; Kaye PM
Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
[TBL] [Abstract][Full Text] [Related]
3. Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.
Paun A; Bankoti R; Joshi T; Pitha PM; Stäger S
PLoS Pathog; 2011 Jan; 7(1):e1001246. PubMed ID: 21253574
[TBL] [Abstract][Full Text] [Related]
4. Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.
Murray HW; Mitchell-Flack M; Zheng H; Ma X
Infect Immun; 2015 Feb; 83(2):702-12. PubMed ID: 25452549
[TBL] [Abstract][Full Text] [Related]
5. Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.
Murray HW; Zhang Y; Zhang Y; Raman VS; Reed SG; Ma X
Infect Immun; 2013 Jul; 81(7):2318-26. PubMed ID: 23589575
[TBL] [Abstract][Full Text] [Related]
6. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.
Nylén S; Maurya R; Eidsmo L; Manandhar KD; Sundar S; Sacks D
J Exp Med; 2007 Apr; 204(4):805-17. PubMed ID: 17389235
[TBL] [Abstract][Full Text] [Related]
7. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
8. Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis.
Murray HW
J Immunol; 2005 Apr; 174(8):4916-23. PubMed ID: 15814719
[TBL] [Abstract][Full Text] [Related]
9. Distinct Roles for CD4
Bunn PT; Montes de Oca M; de Labastida Rivera F; Kumar R; Ng SS; Edwards CL; Faleiro RJ; Sheel M; Amante FH; Frame TCM; Muller W; Haque A; Uzonna JE; Hill GR; Engwerda CR
J Immunol; 2018 Dec; 201(11):3362-3372. PubMed ID: 30355785
[TBL] [Abstract][Full Text] [Related]
10. Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasis.
Kumari S; Jamal F; Shivam P; Thakur A; Kumar M; Bimal S; Das VN; Pandey K; Narayan S; Gupta AK; Das P; Singh SK
Cytokine; 2015 May; 73(1):53-60. PubMed ID: 25697139
[TBL] [Abstract][Full Text] [Related]
11. A Petri net model of granulomatous inflammation: implications for IL-10 mediated control of Leishmania donovani infection.
Albergante L; Timmis J; Beattie L; Kaye PM
PLoS Comput Biol; 2013; 9(11):e1003334. PubMed ID: 24363630
[TBL] [Abstract][Full Text] [Related]
12. Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.
Basu R; Bhaumik S; Haldar AK; Naskar K; De T; Dana SK; Walden P; Roy S
Infect Immun; 2007 Dec; 75(12):5956-66. PubMed ID: 17908806
[TBL] [Abstract][Full Text] [Related]
13. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
[TBL] [Abstract][Full Text] [Related]
14. Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis.
Stanley AC; Zhou Y; Amante FH; Randall LM; Haque A; Pellicci DG; Hill GR; Smyth MJ; Godfrey DI; Engwerda CR
PLoS Pathog; 2008 Feb; 4(2):e1000028. PubMed ID: 18463695
[TBL] [Abstract][Full Text] [Related]
15. STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis.
Oghumu S; Gupta G; Snider HM; Varikuti S; Terrazas CA; Papenfuss TL; Kaplan MH; Satoskar AR
Eur J Immunol; 2014 Feb; 44(2):450-9. PubMed ID: 24242758
[TBL] [Abstract][Full Text] [Related]
16. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
Paul J; Karmakar S; De T
Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
[TBL] [Abstract][Full Text] [Related]
17. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC
PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263
[TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner.
Cotterell SE; Engwerda CR; Kaye PM
Eur J Immunol; 1999 Jan; 29(1):203-14. PubMed ID: 9933102
[TBL] [Abstract][Full Text] [Related]
19. Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell.
Manna PP; Chakrabarti G; Bandyopadhyay S
Vaccine; 2010 Jan; 28(3):803-10. PubMed ID: 19879234
[TBL] [Abstract][Full Text] [Related]
20. Involvement of CD4⁺ Foxp3⁺ regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice.
Tiwananthagorn S; Iwabuchi K; Ato M; Sakurai T; Kato H; Katakura K
PLoS Negl Trop Dis; 2012; 6(8):e1798. PubMed ID: 22928057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
